Skip to main content
. 2018 Jul 17;7(9):4814–4824. doi: 10.1002/cam4.1689

Table 1.

Characteristics and survival time of CUP patients in the canton of Zurich

All Adenocarcinoma Squamous Cell Carcinoma Neuroendocrine carcinoma Unspecified carcinomas Unclassified neoplasms
Patients Total N (%) 2935 (100.0) 1241 (42.3) 193 (6.6) 188 (6.4) 488 (16.6) 825 (28.1)
Men N (%) 1380 (47.0) 538 (43.4) 129 (66.8) 108 (57.4) 259 (53.1) 346 (41.9)
Women N (%) 1555 (53.0) 703 (56.6) 64 (33.2) 80 (42.6) 229 (46.9) 479 (58.1)
Age in years Total Mean ± SD 72.9 ± 12.7 70.7 ± 12.4 69.3 ± 13.0 67.5 ± 13.1 70.1 ± 12.8 80.0 ± 9.9
Median 75.0 73.0 69.0 69.0 72.0 82.0
Men Mean ± SD 71.2 ± 12.3 69.5 ± 11.4 68.8 ± 12.4 66.1 ± 12.7 68.9 ± 13.1 77.9 ± 9.9
Median 73.0 71.0 69.0 68.5 71.0 80.0
Women Mean ± SD 74.5 ± 12.9 71.6 ± 13.1 70.3 ± 14.1 69.4 ± 13.5 71.6 ± 12.3 81.5 ± 9.5
Median 77.0 74.0 69.5 72.0 73.0 84.0
Age groups <60 N (%) 474 (16.1) 247 (19.9) 41 (21.3) 44 (23.4) 109 (22.3) 33 (4.0)
60‐69 N (%) 540 (18.4) 254 (20.5) 57 (29.5) 51 (27.1) 101 (20.7) 77 (9.4)
70‐79 N (%) 882 (30.1) 408 (32.8) 51 (26.4) 58 (30.9) 151 (30.9) 214 (25.9)
>80 N (%) 1039 (35.4) 332 (26.8) 44 (22.8) 35 (18.6) 127 (26.0) 501 (60.7)
Months of Survival Total Mean ± SD 12.3 ± 31.6 10.8 ± 29.2 31.0 ± 54.5 19.6 ± 37.2 13.3 ± 34.5 6.7 ± 17.6
Median (Q1‐Q3) 2.9 (0.9‐9.0) 3.0 (1.0‐8.3) 10.1 (3.1‐26.5) 5.0 (1.5‐21.8) 3.4 (1.1‐9.8) 1.4 (0.5‐4.5)
Men Mean ± SD 11.3 ± 29.1 9.3 ± 26.1 22.3 ± 42.2 21.4 ± 45.3 12.1 ± 29.0 6.1 ± 15.6
Median (Q1‐Q3) 2.7 (0.9‐8.3) 2.6 (0.9‐7.3) 8.3 (3.1‐22.3) 3.7 (1.1‐16.8) 3.2 (1.2‐9.7) 1.3 (0.4‐4.5)
Women Mean ± SD 13.1 ± 33.7 12.0 ± 31.4 47.8 ± 69.9 17.5 ± 23.5 14.7 ± 39.9 7.2 ± 19.1
Median (Q1‐Q3) 3.0 (0.9‐13.1) 2.6 (0.9‐7.3) 16.5 (3.7‐53.5) 3.7 (1.1‐16.8) 3.5 (0.9‐10.2) 1.4 (0.5‐4.5)

N = number, % = in percentage SD = standard deviation, Q1 = quartile 1, Q3 = quartile 3.